2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darwish, HA; Diab, I; Helmy, MW; Motawi, TK; Noureldin, MH | 1 |
| Lazari, MF; Lombardi, AP; Lucas, TF; Pisolato, R; Porto, CS; Vicente, CM | 1 |
| Adami, HO; Andersson, SO; Andrén, O; Brown, M; Calza, S; Chinnaiyan, AM; Demichelis, F; Fall, K; Golub, TR; Hoshida, Y; Johansson, JE; Johnson, LA; Kantoff, PW; Lupien, M; Mertz, KD; Mucci, LA; Pawitan, Y; Perner, S; Rhodes, D; Rubin, MA; Sboner, A; Setlur, SR; Stampfer, MJ; Tang, J; Tomlins, S; Varenhorst, E | 1 |
3 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Cancer of Prostate
| Article | Year |
|---|---|
Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer.
Topics: Anticarcinogenic Agents; Azacitidine; beta Catenin; Caspase 3; Cell Proliferation; Cyclin D1; Decitabine; Disease Progression; Epigenesis, Genetic; Estrogen Receptor beta; Hormones; Humans; Hydroxamic Acids; Male; Methylation; Nitriles; Propionates; Prostate; Prostatic Neoplasms; Vascular Endothelial Growth Factor A | 2018 |
Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
Topics: beta Catenin; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin D2; Cycloheximide; Estradiol; Estrogen Receptor beta; Humans; Male; Nitriles; Phenols; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Thymidine | 2016 |
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Topics: Antineoplastic Agents, Hormonal; Area Under Curve; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; DNA, Complementary; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Health Surveys; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Oncogene Proteins, Fusion; Phenols; Physicians; Polymerase Chain Reaction; Propionates; Prostatic Neoplasms; Pyrazoles; Serine Endopeptidases; Signal Transduction; Sweden; Transfection | 2008 |